“a significant trend”

When analyzed categorically, participants in the highest MLR tertile (T3) maintained a significantly elevated odds of PAD even in the fully adjusted model (Model 5: OR = 2.25, p = 0.008), with a significant trend across tertiles ( p = 0.008).

Those who were extremely religious were significantly less likely to be vaccinated (aOR = 0.5; 95% CI: 0.3–0.9) compared to individuals who were not at all religious, and there was a significant trend of decreasing likelihood of COVID-19 receipt with increasing religiosity ( p = 0.008).

A significant trend indicated a lower OS as the N status increased (for N0: 42 [95% CI 34–50) months; N1: 32 [95% CI 28–36] months; N2: 24 [95% CI 14–35] months; p = 0.008).

Figure 1 and Figure 2 depicted a significant trend association between the case numbers and the seasonal and monthly temperatures ( p = 0.008 and p = 0.005). 3.5.

A multiple comparison following a significant trend of CPK levels in the intervention and control group 1, with a corrected level of significance based on the Bonferroni correction (P<0.008), was applied.

The Cochran–Armitage trend test revealed a significant trend of a higher prevalence of VA in the order of STTH, N-STTH, and NMNT headache ( P = 0.008) ( Fig. 2 ).

The subgroup analysis by analgesic type in our meta-analysis revealed a significant trend toward reduced PCA use with ESPB compared to morphine (MD: -8.78, 95%CI: -15.34 to -2.22, P = 0.009).

Similarly, a significant trend towards better outcomes was observed with increasing Kawaguchi scores ( p = 0.009), with grade 1 tumors having a 51.7% lower probability of good outcomes compared to grade 3 ( Figure 4 and Figure 5 ).

In addition, meta-regression of serum gastrin elevation ( Figure 4(e) and ( f )) revealed a significant positive correlation with both treatment duration and vonoprazan dosage, where longer therapy was associated with greater gastrin elevation compared with lansoprazole (coefficient = 1.7972 per week, p < 0.0001) and higher vonoprazan doses showed a significant trend toward increased gastrin levels (coefficient = 9.3422 per mg, p = 0.0093).

Comparison of the distribution of SCAI SHOCK stages revealed a significant trend towards a higher proportion of stages D (64.7% vs. 25.0%, P < 0.01) among the 1‐year non‐survivors.

Comparison of the distribution of SCAI Shock stages revealed a significant trend towards a higher proportion of stages D (58.9% vs. 47.2%) and E (1.8% vs. 0.4%) ( P = 0.01) among the 1‐year non‐survivors.

The average changes in ln(UACR) for participants in the 2nd, 3rd, and 4th quartiles relative to the reference quartile were respectively − 0.06, 0.08, and 0.22, presenting a significant trend ( P < 0.01).

There was a significant trend (Armitage trend test p < 0.01) of decreasing IFI incidence with increasing GA, falling from 4.6% at 22–23 weeks GA to 0.2% at 28 weeks GA ( Figure 3 ).

However, a significant trend of higher LN count and higher likelihood of liver metastases was observed ( P = 0.010).

There was a significant trend for White patients to be more readily offered CAR-T than their non-White counterparts (offered CAR-T: 29% vs 6%; P <0.01), with BsAbs also more likely offered to White patients (offered BsAbs: 21% vs 8%; P =0.096).

A significant trend towards increased AZM resistance over time was observed (R 2 =0.32, P <0.01; Fig.

However, among kidney transplant patients younger than 50 years at the time of transplantation ( n = 754), there was a significant trend for increasing the occurrence of post-transplant CV complications along the consecutive KDRI quartiles (χ 2 = 7.3; p < 0.01), with the frequency of CVEs across the study groups as follows: Q1 13/205, Q2 23/179, Q3 24/166, and Q4 21/123.

There was a significant trend toward higher WFDC2 expression in patients with low PDCD1 expression (p = 0.01).

Regression analysis indicated a significant trend ( P =.01) increase in app release, with a 2.40 unit increase per year before 2020 and a 7.01 unit decrease after, showing a post-2020 decline of 4.61 units per year.

The results demonstrate a significant trend in pain changes in the exercise group (F (2, 24) = 5.31, P = 0.01, η 2 = 0.31), while it is not significant in the control group (F (2, 30) = 0.57, P = 0.57, η 2 = 0.04).

Compared with the latter, our cohort presented increased mutation frequency of DUSP2 , BTG2 , IRF4 , MEF2B , MYC , CD79B , BCL7A , NFKBIE , FAS , and CIITA ( p < 0.05), with a significant trend toward changes in TP53 , CCND3 , CD58 , and CXCR4 ( p < 0.01).

With respect to transcendent orientation, the mean score was higher in women ( P = 0.03) and in those working < 30 h/week ( P = 0.03); a significant trend also emerged in the mean COPE-NIV-25 score, which increased with age ( P = 0.01) and length of employment ( P = 0.01).

The sensitivity analysis results revealed a significant trend across UACR tertiles and ACM among participants aged <80 and with no CVD history, respectively ( p < 0.01 for trend). 3.3 ROC analysis of UACR predictive value for ACM in DM The ROC analysis results demonstrated the UACR prognostic value for ACM.

Similarly, there was a significant trend in all item scores (with the exception of environmental autonomy) across the cognitive subgroups (all p<0.01).

The fully adjusted model demonstrated a significant trend correlating increased TTHC (P<0.01 for trend), SR (P<0.001 for trend), and Ki-67 expression (P=0.004 for trend) with ALNM.